Abstract
ON THE COVERGenetics and Preventive Medicine: A Time for InquiryThe Role of Genomics in Public Health and Disease PreventionThe Genetics of Sudden DeathGenomics in Medicine and Public Health: Role of Cost-effectiveness AnalysisGenomic Medicine: Managing the Complexity
Highlights
MSJAMA provides a forum for critical exchange on current issues in medical education, research and practice
Following its release, British Prime Minister Tony Blair declared, “Today we are witnessing a revolution in medical science whose impact can far surpass the discovery of antibiotics.”[1]. And just 5 days prior, fears about the creation of a “genetic ghetto” swirled around London when one of Britain’s largest private life insurers to revealed that it had illegally used data from experimental genetic tests to evalute some insurance applications.[2]
A cost-effectiveness analysis can illustrate the relationship between the net resources used and the net health benefits gained for a specific clinical intervention compared with an alternative
Summary
MSJAMA provides a forum for critical exchange on current issues in medical education, research and practice. Through painstaking research, will the true social and medical impact of genetic science be clarified This issue of MS JAMA explores how researchers, policy makers, and clinicians are defining a role for genetics in preventive medicine. In realizing the benefits of genetic testing in disease prevention, physicians and policy makers must establish mechanisms to evaluate and respond to the implications of new genetic information as soon as it becomes available. They can thereby protect the public, from disease, and from alarmists and profiteers
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
